“The Company intends to use the net proceeds of the Offering to partially fund the development of its facilities in Kincardine, Ontario and for general corporate purposes.” http://www.supreme.ca/news/press-release-details/2017/Supreme-Pharmaceuticals-Closes-4025-Million-Bought-Deal-Private-Placement-of-Convertible-Debenture-Units/default.aspx